Table 1: Gene Therapy Targets and Strategies for Ablation of Atrial Fibrillation.
Study | Type of Strategy | Transgene or Target | Findings | Species | Vector | Delivery Method |
Rhythm Control | ||||||
Kikuchi et al. 200533 | Reentry-disrupting interventions by prolongation of APD | Human KCNH2-G628S | Atrial APD prolongation. No ventricular effects. Arrhythmia suppression not tested. | Swine | Ad | Epicardial painting |
Atrial APD prolongation eliminated burst pacing-induced AF | Swine | Ad | Epicardial painting | |||
Amit et al.201063 | Canine | Swine | Ad | Myocardial injection and electroporation | ||
Soucek et al.201246 | KCNH2-G627S | |||||
Igarashi et al. 201264 | Reentry-disrupting interventions by improvement of atrial conduction velocity | GJA1, GJA5 | Improved atrial conduction and prevented AF | Swine | Ad | Epicardial painting |
Bikou et al. 201134 | GJA1 | Swine | Ad | Myocardial injection and electroporation | ||
Liu et al. 200873 | HDAC class I and II inhibitor | HDAC inhibition reduced atrial arrhythmia inducibility and atrial fibrosis | Transgenic mice | NA | ||
Trappe et al. 201347 | CASP3 inhibitor | Knockdown of caspase 3 suppressed or delayed sustained AF by reducing atrial cardiomyocyte apoptosis | Swine | Ad | Myocardial injection and electroporation | |
Li et al. 201276 and 201493 | Trigger-disruption by preventing Ca2+ leak from SR | CAMK2D inhibitor | Inhibition of CaMKII phosphorylation of RyR2 prevented AF induction | Transgenic mice | NA | |
Rate Control | ||||||
Donahue et al. 200031 | Modification of AV node of AV node | GNAI2 | Suppressed AV conduction and reduced ventricular rate by 20 % in anesthetised animals | Swine | Ad | Intracoronary perfusion and catheterisation |
Bauer et al. 200480 | GNAI2-Q205L | Suppressed AV conduction and reduced ventricular rate ~20 % in alert animals | Swine | Ad | Intracoronary perfusion and catheterisation | |
Lugenbiel et al. 201282 | Modification of SA node | GNAS siRNA | Suppression of Gαs protein expression reduced ventricular rate by 8–17 % during SR | Swine | Ad | Myocardial injection and electroporation, |
Murata et al. 200481 | Suppress L-type Calcium channel | GEM | Gem gene transfer to AV node reduced the heart rate by 20 % during AF | Swine | Ad | Intracoronary catheterisation |
AF = atrial fibrillation; SR = sinus rhythm, Ad = Adenovirus; AV = atrioventricular; APD = action potential duration; NA = not available.